Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.
2Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. 3Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, ...
Here the authors report that NPC1 prevents ubiquitylation and degradation of TGF-β receptor 1, leading to activation of the TGF-β pathway and hepatocellular carcinoma progression.
but the primary site is found later. Still, the American Cancer Society estimates that about 37,370 cases of cancer of unknown primary will be diagnosed in 2025 in the United States. This number ...
The quantitative effects of alcohol consumption on cirrhosis and hepatocellular carcinoma (HCC) in hepatitis B virus (HBV) infection are unknown. This ...
Evidence for transcoelomic dissemination versus transcoelomic metaplasia in ovarian cancer is presented. Future high throughput microarray studies that compare changes at a genomic and gene expression ...